[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"norm-eurlex-reg_2024_352-erwgr-9-de":3},{"law":4,"norm_id":14,"norm_key":15,"slug":16,"title":17,"chapter":18,"content":19,"enriched_content":20,"hierarchy":21,"neighbors_before":22,"neighbors_after":32,"citing_decisions":42,"is_thin":43},{"abbreviation":5,"title":6,"source_type":7,"jurisdiction":8,"document_kind":9,"language":10,"attribution":11,"version_date":12,"source_url":13},"reg_2024_352","zur Änderung der Anhänge II und V der Verordnung (EG) Nr. 396\u002F2005 des Europäischen Parlaments und des Rates hinsichtlich der Höchstgehalte an Rückständen von (Z)-13-Hexadecen-11-yn-1-yl-acetat, (Z,Z,Z,Z)-7,13,16,19-Docosatetraen-1-yl-isobutyrat, Acrinathrin, Azimsulfuron, Famoxadon, Prochloraz und Natriumhypochlorit in oder auf bestimmten Erzeugnissen","eurlex","eu","regulation","de","© Europäische Union, https:\u002F\u002Feur-lex.europa.eu","2024-02-01","https:\u002F\u002Feur-lex.europa.eu\u002Flegal-content\u002FDE\u002FALL\u002F?uri=CELEX:32024R0352",7128707,"ErwGr. 9","erwgr-9",null,"Erwägungsgründe","Die Verordnung (EG) Nr. 396\u002F2005 sollte daher entsprechend geändert werden.","REG_2024_352 - Erwägungsgründe - ErwGr. 9\n\nDie Verordnung (EG) Nr. 396\u002F2005 sollte daher entsprechend geändert werden.",{},[23,26,29],{"norm_key":24,"title":17,"slug":25},"ErwGr. 8","erwgr-8",{"norm_key":27,"title":17,"slug":28},"ErwGr. 7","erwgr-7",{"norm_key":30,"title":17,"slug":31},"ErwGr. 6","erwgr-6",[33,36,39],{"norm_key":34,"title":17,"slug":35},"ErwGr. 10","erwgr-10",{"norm_key":37,"title":17,"slug":38},"ErwGr. 11","erwgr-11",{"norm_key":40,"title":17,"slug":41},"ErwGr. 12","erwgr-12",[],true]